UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 25, 2010
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 000-10030
Apple Inc.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
Registrant s telephone number, including area code: (408) 996-1010
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
921,278,012 shares of common stock issued and outstanding as of January 7, 2011
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in millions, except share amounts which are reflected in thousands and per share amounts)
Three Months Ended
December 25,
2010
December 26,
2009
Net sales
26,741
15,683
Cost of sales
16,443
9,272
Gross margin
10,298
6,411
Operating expenses:
Research and development
575
398
Selling, general and administrative
1,896
1,288
Total operating expenses
2,471
1,686
Operating income
7,827
4,725
Other income and expense
136
33
Income before provision for income taxes
7,963
4,758
Provision for income taxes
1,959
1,380
Net income
6,004
3,378
Earnings per common share:
Basic
6.53
3.74
Diluted
6.43
3.67
Shares used in computing earnings per share:
Basic
919,294
903,542
Diluted
933,154
919,783
See accompanying Notes
to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except
share amounts)
December 25,
2010
September 25,
2010
ASSETS:
Current assets:
Cash and cash equivalents
10,734
11,261
Short-term marketable securities
16,243
14,359
Accounts receivable, less allowances of $62 and $55, respectively
6,027
5,510
Inventories
885
1,051
Deferred tax assets
1,724
1,636
Vendor non-trade receivables
4,847
4,414
Other current assets
3,467
3,447
Total current assets
43,927
41,678
Long-term marketable securities
32,730
25,391
Property, plant and equipment, net
5,868
4,768
Goodwill
741
741
Acquired intangible assets, net
522
342
Other assets
2,954
2,263
Total assets
86,742
75,183
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
14,301
12,015
Accrued expenses
5,953
5,723
Deferred revenue
3,541
2,984
Total current liabilities
23,795
20,722
Deferred revenue non-current
1,216
1,139
Other non-current liabilities
7,065
5,531
Total liabilities
32,076
27,392
Commitments and contingencies
Shareholders equity:
Common stock, no par value; 1,800,000,000 shares authorized; 921,035,475 and 915,970,050 shares issued and outstanding,
respectively
11,502
10,668
Retained earnings
43,050
37,169
Accumulated other comprehensive income/(loss)
114
(46
Total shareholders equity
54,666
47,791
Total liabilities and shareholders equity
86,742
75,183
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
Three Months Ended
December 25,
2010
December 26,
2009
Cash and cash equivalents, beginning of the period
11,261
5,263
Operating activities:
Net income
6,004
3,378
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation, amortization and accretion
356
209
Stock-based compensation expense
299
205
Deferred income tax expense
823
425
Changes in operating assets and liabilities:
Accounts receivable, net
(517
271
Inventories
166
(121
Vendor non-trade receivables
(433
(95
Other current and non-current assets
(558
(369
Accounts payable
2,346
956
Deferred revenue
634
606
Other current and non-current liabilities
653
316
Cash generated by operating activities
9,773
5,781
Investing activities:
Purchases of marketable securities
(19,575
(12,922
Proceeds from maturities of marketable securities
3,279
6,216
Proceeds from sales of marketable securities
6,853
3,199
Payments for acquisition of property, plant and equipment
(1,214
(376
Payments for acquisition of intangible assets
(49
(5
Other
(23
(70
Cash used in investing activities
(10,729
(3,958
Financing activities:
Proceeds from issuance of common stock
208
374
Excess tax benefits from stock-based compensation
454
252
Taxes paid related to net share settlement of equity awards
(233
(103
Cash generated by financing activities
429
523
(Decrease)/increase in cash and cash equivalents
(527
2,346
Cash and cash equivalents, end of the period
10,734
7,609
Supplemental cash flow disclosure:
Cash paid for income taxes, net
826
980
See accompanying Notes
to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures, and
markets personal computers, mobile communication and media devices, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications. The
Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as third-party cellular network carriers, wholesalers, resellers and value-added resellers. In addition, the Company sells a variety of
third-party Macintosh ( Mac ), iPhone, iPad and iPod compatible products including application software, printers, storage devices, speakers, headphones, and various other accessories and supplies through its online and retail stores. The
Company sells to consumer, small and mid-sized business, education, enterprise, government and creative markets.
Basis of Presentation and
Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany
accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and
assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior year amounts in the condensed consolidated financial
statements and notes thereto have been reclassified to conform to the current period s presentation.
These condensed
consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal year ended September 25, 2010, included in its Annual
Report on Form 10-K (the 2010 Form 10-K ). Unless otherwise stated, references to particular years or quarters refer to the Company s fiscal years ended in September and the associated quarters of those fiscal years.
During the first quarter of 2011, the Company adopted the Financial Accounting Standard Board s ( FASB ) new accounting
standard on consolidation of variable interest entities. This new accounting standard eliminates the mandatory quantitative approach in determining control for evaluating whether variable interest entities need to be
consolidated in favor of a qualitative analysis, and requires an ongoing reassessment of control over such entities. The adoption of this new accounting standard did not impact the Company s condensed consolidated financial
statements.
Earnings Per Common Share
Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per
common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have
been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding options, shares to be purchased under the employee stock purchase plan, and unvested restricted stock units
( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the
Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table sets forth the computation of basic and diluted earnings per common
share for the three months ended December 25, 2010 and December 26, 2009 (in thousands, except net income in millions and per share amounts):
Three Months Ended
December 25,
2010
December 26,
2009
Numerator:
Net income
6,004
3,378
Denominator:
Weighted-average shares outstanding
919,294
903,542
Effect of dilutive securities
13,860
16,241
Weighted-average diluted shares
933,154
919,783
Basic earnings per common share
6.53
3.74
Diluted earnings per common share
6.43
3.67
Potentially dilutive
securities representing approximately 83,000 shares and 1.8 million shares of common stock for the quarters ended December 25, 2010 and December 26, 2009, respectively, were excluded from the computation of diluted earnings per common
share for these periods because their effect would have been antidilutive.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables
summarize the Company s available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short-term or long-term
marketable securities as of December 25, 2010 and September 25, 2010 (in millions):
December 25, 2010
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
3,000
3,000
3,000
Money market funds
1,470
1,470
1,470
U.S. Treasury securities
8,368
16
(23
8,361
1,537
2,112
4,712
U.S. agency securities
10,821
(10
10,818
1,200
4,467
5,151
Non-U.S. government securities
4,328
11
(4
4,335
1,318
3,008
Certificates of deposit and time deposits
3,639
(1
3,639
1,342
943
1,354
Commercial paper
3,871
3,871
2,134
1,737
Corporate securities
21,704
72
(35
21,741
39
5,283
16,419
Municipal securities
2,474
(9
2,472
383
2,086
Total cash, cash equivalents and marketable securities
59,675
114
(82
59,707
10,734
16,243
32,730
September 25, 2010
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
1,690
1,690
1,690
Money market funds
2,753
2,753
2,753
U.S. Treasury securities
9,872
42
9,914
2,571
2,130
5,213
U.S. agency securities
8,717
10
8,727
1,916
4,339
2,472
Non-U.S. government securities
2,648
13
2,661
10
865
1,786
Certificates of deposit and time deposits
2,735
(1
2,739
374
850
1,515
Commercial paper
3,168
3,168
1,889
1,279
Corporate securities
17,349
102
(9
17,442
58
4,522
12,862
Municipal securities
1,899
19
(1
1,917
374
1,543
Total cash, cash equivalents and marketable securities
50,831
191
(11
51,011
11,261
14,359
25,391
The Company had net unrealized gains on its investment portfolio of $32 million and $180 million as of
December 25, 2010 and September 25, 2010, respectively. The net unrealized gains as of December 25, 2010 and September 25, 2010 related primarily to long-term marketable securities. The Company may sell certain of its marketable
securities prior to their stated maturities for strategic purposes for reasons, including but not limited to, anticipation of credit deterioration and duration management. The Company recognized no significant net realized gains or losses during the
first quarter of 2011 or 2010 related to such sales. The maturities of the Company s long-term marketable securities generally range from one year to five years.
As of December 25, 2010, the Company had $1 million of gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer. The fair value of
the individual securities that had been in a continuous loss position for 12 months or longer as of December 25, 2010 was $518 million. The Company had $11 million of gross unrealized losses as of September 25, 2010, of which an
insignificant amount had been in a continuous loss position for 12 months or longer.
The Company considers the declines in
market value of its marketable securities investment portfolio to be temporary in nature. The Company typically invests in highly-rated securities, and its policy generally limits the amount of credit exposure to any one issuer. The Company s
investment policy requires investments to be investment grade, primarily rated single-A or better, with the objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment
portfolio. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes
thereto, and the Company s intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment s amortized cost basis. During the first quarters of 2011 and 2010, the Company
did not recognize any significant impairment charges. As of December 25, 2010, the Company does not consider any of its investments to be other-than-temporarily impaired.
Derivative Financial Instruments
The Company uses derivatives to partially
offset its business exposure to foreign currency exchange risk. The Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk of expected future cash flows on certain forecasted revenue and cost
of sales, of net investments in certain foreign subsidiaries, and on certain existing assets and liabilities. To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose
functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted
inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases for three to six months. To help
protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments
due to fluctuations in foreign currency exchange rates. The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain
assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons, including but not limited to immateriality, accounting considerations
and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.
The Company s accounting policies for these instruments are based on whether the
instruments are designated as hedge or non-hedge instruments. The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The effective portions of cash flow hedges are recorded in other comprehensive income until
the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. Derivatives that are not designated as hedging instruments and
the ineffective portions of cash flow hedges and net investment hedges are adjusted to fair value through earnings in other income and expense.
The Company had a net deferred loss associated with cash flow hedges of approximately $9 million and $252 million, net of taxes, recorded in other comprehensive income as of December 25, 2010 and
September 25, 2010, respectively. Other comprehensive income associated with cash flow hedges of foreign currency revenue is recognized as a component of net sales in the same period as the related revenue is recognized, and other comprehensive
income related to cash flow hedges of inventory purchases is recognized as a component of cost of sales in the same period as the related costs are recognized. Substantially all of the Company s hedged transactions as of December 25, 2010
are expected to occur within six months.
Derivative instruments designated as cash flow hedges must be de-designated as
hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in other comprehensive income associated with such derivative
instruments are reclassified immediately into earnings through other income and expense. Any subsequent changes in fair value of such derivative instruments also are reflected in current earnings unless they are re-designated as hedges of other
transactions. The Company did not recognize any material net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the first quarter of 2011 or 2010.
The Company had an unrealized net gain on net investment hedges of $3 million and an unrealized net loss on net investment hedges of $9
million, net of taxes, included in the cumulative translation adjustment account of accumulated other comprehensive income ( AOCI ) as of December 25, 2010 and September 25, 2010, respectively. The ineffective portions and
amounts excluded from the effectiveness test of net investment hedges are recorded in current earnings in other income and expense.
The Company recognized in earnings a net gain of $29 million and a net loss of $34 million on foreign currency forward and option contracts not designated as hedging instruments during the first quarter
of 2011 and 2010, respectively. These amounts represent the net gain or loss on the derivative contracts and do not include changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.
The following table shows the notional principal amounts of the Company s outstanding derivative instruments and credit
risk amounts associated with outstanding or unsettled derivative instruments as of December 25, 2010 and September 25, 2010 (in millions):
December 25, 2010
September 25, 2010
Notional
Principal
Credit
Risk
Amounts
Notional
Principal
Credit
Risk
Amounts
Instruments qualifying as accounting hedges:
Foreign exchange contracts
11,193
113
13,957
62
Instruments other than accounting hedges:
Foreign exchange contracts
10,613
82
10,727
45
The notional principal amounts for outstanding derivative instruments provide one measure of
the transaction volume outstanding and does not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments
that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. The Company s gross exposure on these transactions may be
further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. Although the table above reflects the notional principal
and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately
realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The Company generally enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with
the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from
contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of December 25, 2010, the Company received cash collateral related to the derivative instruments under
its collateral security arrangements of $77 million and recorded the offsetting balance as accrued expenses in the Condensed Consolidated Balance Sheet. As of September 25, 2010, the Company posted cash collateral related to the derivative
instruments under its collateral security arrangements of $445 million and recorded the offsetting balance as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have any derivative instruments with credit
risk-related contingent features that would require it to post additional collateral as of December 25, 2010 or September 25, 2010.
The estimates of fair value are based on applicable and commonly used pricing models and prevailing financial market information as of December 25, 2010 and September 25, 2010. Refer to Note 3,
Fair Value Measurements of this Form 10-Q, for additional information on the fair value measurements for all financial assets and liabilities, including derivative assets and derivative liabilities, that are measured at fair value in the
condensed consolidated financial statements on a recurring basis. The following tables show the Company s derivative instruments measured at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of December 25, 2010
and September 25, 2010 (in millions):
December 25, 2010
Fair Value of
Derivatives
Designated as
Hedge Instruments
Fair Value of
Derivatives Not
Designated as
Hedge Instruments
Total
Fair Value
Derivative assets (a):
Foreign exchange contracts
112
82
194
Derivative liabilities (b):
Foreign exchange contracts
87
21
108
September 25, 2010
Fair Value of
Derivatives
Designated as
Hedge Instruments
Fair Value of
Derivatives Not
Designated as
Hedge Instruments
Total
Fair Value
Derivative assets (a):
Foreign exchange contracts
62
45
107
Derivative liabilities (b):
Foreign exchange contracts
488
118
606
(a)
All derivative assets are recorded as other current assets in the Condensed Consolidated Balance Sheets.
(b)
All derivative liabilities are recorded as accrued expenses in the Condensed Consolidated Balance Sheets.
The following table shows the pre-tax effect of the Company s derivative instruments
designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three months ended December 25, 2010 and December 26, 2009 (in millions):
Gains/(Losses) Recognized in
OCI - Effective Portion (c)
Gains/(Losses) Reclassified
from AOCI into Income -
Effective Portion (c)
Gains/(Losses) Recognized -
Ineffective
Portion and Amount Excluded from
Effectiveness Testing
December 25,
2010
December 26,
2009
December 25,
2010 (a)
December 26,
2009 (b)
Location
December 25,
2010
December 26,
2009
Cash flow hedges:
Foreign exchange contracts
(66
12
(449
(20
Other income
and expense
21
(14
Net investment hedges:
Foreign exchange contracts
(3
(1
Other income
and expense
Total
(69
11
(449
(20
21
(14
(a)
Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(257) million and $(192)
million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended December 25, 2010. There were no amounts reclassified from AOCI into net income for
the effective portion of net investment hedges for the three months ended December 25, 2010.
(b)
Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $2 million and ($22) million
were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended December 26, 2009. There were no amounts reclassified from AOCI into net income for the
effective portion of net investment hedges for the three months ended December 26, 2009.
(c)
Refer to Note 6, Shareholders Equity and Stock-Based Compensation of this Form 10-Q, which summarizes the activity in AOCI related
to derivatives.
Accounts Receivable
The Company has considerable trade receivables not covered by collateral, third-party financing arrangements or credit insurance outstanding with its third-party cellular network carriers, wholesalers,
retailers, and value-added resellers, and directly to certain education, consumer and enterprise customers. There was one customer that represented 10% of the Company s trade receivables as of December 25, 2010. Trade receivables from two
of the Company s customers accounted for 15% and 12% of trade receivables as of September 25, 2010. The Company s cellular network carriers accounted for 54% and 64% of trade receivables as of December 25, 2010 and
September 25, 2010, respectively. Additionally, the Company has non-trade receivables from certain of its manufacturing vendors. Vendor non-trade receivables from two of the Company s vendors accounted for 55% and 27%, respectively, of
non-trade receivables as of December 25, 2010 and two of the Company s vendors accounted for 57% and 24%, respectively, of non-trade receivables as of September 25, 2010.
10
Note 3 Fair Value Measurements
The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When
determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk
measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.
The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of
input that is available and significant to the fair value measurement:
Level 1 Quoted prices in active markets
for identical assets or liabilities.
Level 2 Observable inputs other than quoted prices in active markets for
identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or
liabilities.
Level 3 Inputs that are generally unobservable and typically reflect management s estimates
of assumptions that market participants would use in pricing the asset or liability.
The Company s valuation techniques
used to measure the fair value of money market funds and certain marketable equity securities were derived from quoted prices in active markets for identical assets or liabilities. The valuation techniques used to measure the fair value of all other
financial instruments, all of which have counterparties with high credit ratings, were valued based on quoted market prices or model driven valuations using significant inputs derived from or corroborated by observable market data.
Assets and Liabilities Measured at Fair Value
The following tables present the Company s assets and liabilities measured at fair value, which also represents the related carrying amounts, on a recurring basis as of December 25, 2010 and